Healthy patient Adjustable-depth fractional microneedle bipolar radiofrequency,Wrinkle and Facial Contouring
Conditions
Interventions
Patients were treated with Morpheus8 for 1 session then they were instructed to follow up at 1 month, 3 months, 6 months after the last treatments.
Experimental Device
Sponsors
ASTRACO MEDICAL NETWORKS LTD.
Eligibility
Sex/Gender
All
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Aged 25-55 years 2. Both male and Female 3.mild to moderate skin laxity
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant 2. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin 3. Subjects who has dermatits, wound or infection at treatment area 4. Subjects who allergy to anesthesia cream 5. Subjects who taken oral or injection contraceptive pills 6. Subjects who had history of melasma treatment within 6 months before arrived the project 7. Subjects who had history of laser at treatment area within 6 months before arrived the project 8. Subjects who had history of keloid or hypertrophic scar 9. Subjects who had history of psychitic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume change Baseline, 1 month,3 months, 6 months Vectra | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin Texture and Wrinkle Baseline, 1 month,3 months, 6 months Antera,Doctor evaluation 1 month,3 months, 6 months Quatile scale,Patient evaluation 1 month,3 months, 6 months Quatile scale,Pain score 1 month,3 months, 6 months Visual analog scale,safety 1 month,3 months, 6 months Adverse effect | — |
Countries
Thailand
Contacts
Public ContactThanya Techapichetvanich
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed